Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cell Targeting

2004 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
$2.4M LATEST DEAL AMOUNT
Description

Developer of a stem cell technology intended to take cell therapy products to a new level of performance. The company's stem cell technology uses peptides to coat therapeutic cells using techniques that do not modify cell physiology, enabling users to elevated performance of cell therapy products.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Acquirer
Primary Office
  • Cleveland, OH
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cell Targeting’s full profile, request a free trial.

Cell Targeting Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 28-Jan-2011 $2.4M 000 00.00 Completed Generating Revenue
3. Angel (individual) 01-Apr-2008 000 000 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Grant Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Cell Targeting Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Defense Advanced Research Projects Agency Government 000 0000 000000 0
Global Cardiovascular Innovation Center Accelerator/Incubator Minority 000 0000 000000 0
Toucan Ventures Other Minority 000 0000 000000 0